HIV and AIDS Trial, Recruiting (NCT06202898)

HIV and AIDS Trial, Recruiting NCT06202898 Sponsor: University of Central Florida Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06202898 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who were male at birth
People who identify as a woman or transgender woman
People who are not currently taking PrEP consistently (meaning fewer than four doses per week)
People who have no known allergy or bad reaction to PrEP or its active ingredient tenofovir (which is also found in some HIV treatments)
People who can speak and understand English and/or Spanish, including those who cannot read or write
People who own a smartphone that can take photos

Who may not be able to join:

People who are unwilling to follow the study's procedures
People who are currently taking part in an HIV vaccine trial
People who have a severe, life-threatening substance use disorder
People who have any health condition that trial staff believe would make participation unsafe or would get in the way of the study's goals, including conditions that prevent the use of PrEP (confirm with trial site)
People who are unable to give their informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elena Cyrus, PhD, University of Central Florida

Phone: 4072661507

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06202898

Sponsor: University of Central Florida

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 4072661507

More information: https://clinicaltrials.gov/study/NCT06202898

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who were male at birth
People who identify as a woman or transgender woman
People who are not currently taking PrEP consistently (meaning fewer than four doses per week)
People who have no known allergy or bad reaction to PrEP or its active ingredient tenofovir (which is also found in some HIV treatments)
People who can speak and understand English and/or Spanish, including those who cannot read or write
People who own a smartphone that can take photos

Who may not be able to join:

People who are unwilling to follow the study's procedures
People who are currently taking part in an HIV vaccine trial
People who have a severe, life-threatening substance use disorder
People who have any health condition that trial staff believe would make participation unsafe or would get in the way of the study's goals, including conditions that prevent the use of PrEP (confirm with trial site)
People who are unable to give their informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Central Florida

Registry

ClinicalTrials.gov

Start date

11 July 2023

Est. completion

1 November 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with substance abuse

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov